Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Nanoform grant Global STARMAP® AI License to AstraZeneca
Contributed by:
PR Newswire
Tags
NANOFORM
More Like This
Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned
Inside information made public: Nanoform Wins R&D Grant of EUR 4.3M for Research Into Nanoparticle Enabled Formulations for Next Generation Medicines
Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide
Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide
NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT
Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer
Sofinnova Partners Portfolio Company Amolyt Pharma to be Acquired by AstraZeneca
Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease
